Comments on NIST Proposed Revisions to Bayh-Dole Act

(KEI has an email list to discuss this issue here: http://lists.keionline.org/mailman/listinfo/bayh-dole-regulations_lists.keionline.org) The Department of Commerce’s National Institute of Standards and Technology (NIST) published on January 4, 2021, a request for comments on changes in regulations related to the Bayh-Dole Act… Continue Reading

Texas A&M Vaccine Manufacturing Contract Shows that cGMP Manufacturing of COVID-19 Vaccines Can Start in Five Months 

A $265 million COVID-19 vaccine manufacturing contract between the Department of Health and Human Services (HHS) and the Texas A&M University System (TAMUS) to manufacture the Novavax and other COVID-19 vaccines demonstrates that a manufacturing facility can be retrofitted to… Continue Reading

Bolivia seeks to import COVID-19 vaccines from Biolyse, if Canada grants them a compulsory license

Today, May 11, 2021, the government of Bolivia and Biolyse, a company based in Canada, signed an agreement to acquire COVID-19 vaccines manufactured by the company, if Canada grants them a compulsory license. Biolyse is a manufacturer of cancer drugs… Continue Reading

KEI submission to Canada Standing Committee on International Trade and Investment Policy: Concerning COVID-19

Brief to Standing Committee on International Trade and Investment Policy: Selected Consideration Concerning COVID-19 Vaccines Knowledge Ecology International James Love and Arianna Schouten 30 April 2021 This brief will discuss (1) the scope and purpose of the proposed World Trade… Continue Reading

KEI Comments on NIH Exclusive License to Australian firm SubRed

On Monday April 26, 2021, Knowledge Ecology International submitted comments regarding the “Prospective Grant of an Exclusive Patent License: N-butyldeoxynojirimycin To Treat Smith-Lemli Opitz Syndrome (SLOS) and Diseases That Exhibit a Similar NPC-Like Cellular Phenotype” (86 FR 18545) by the… Continue Reading

41 Canadian Experts Request Amendment to Schedule 1 of the Patent Act to include COVID-19 vaccines

On April 27th, a letter signed by 41 Canadian experts was sent to the Prime Minister of Canada, the Minister of Innovation, Science & Industry, and the Minister of Health. The letter requests the amendment of Schedule 1 of the… Continue Reading

KEI Statement at WTO COVID-19 Vaccine Equity Event

On Wednesday April 14, 2021, the World Trade Event hosted an event titled “COVID-19 and Vaccine Equity: What can the WTO contribute?” which featured three sessions concerning vaccine distribution, manufacturing, and looking forward at how the system could better address… Continue Reading

KEI Comments Regarding NIH Exclusive License to Memorial Sloan Kettering Cancer Center

(Update: The NIH provided a response to our comments on April 15, 2021.) Knowledge Ecology International (KEI) submitted comments on April 14, 2021 to the Federal Register notice for the National Institutes of Health’s (NIH) “Prospective Grant of Exclusive Patent… Continue Reading

KEI Comments on NIH Exclusive License to Norwegian Firm Zelluna

(Update: The NIH provided a response to our comments on April 15, 2021.) On Wednesday April 14, 2021, Knowledge Ecology International (KEI) filed comments with the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License:… Continue Reading